Description
Multiple Sclerosis – Practical Comprehensive Essentials
Prof. Dr. Mike K.S. Chan and Dr. Dina Tulina
Table of Content
Foreword | vii |
Abbreviations | ix |
Introduction and Disease Pathogenesis | xi |
PART I | 1 |
Pathology and Diagnosis | 1 |
1.1 Aetiology | 1 |
1.2 Epidemiology and Genetics | 5 |
1.3 Pathophysiology | 8 |
1.4 Classification | 11 |
1.5 The Course of MS | 15 |
1.6 Clinical Features | 16 |
1.7 Cognitive Impairment in MS | 18 |
1.8 Diagnosis and Magnetic Resonance Imaging | 20 |
PART II | 25 |
Management | 25 |
2.1 Treatment and Prevention | 25 |
Immune -Modulating Peptides (Transfer Factor) | 27 |
Active Specific Immunotherapy (ASI) Theraphy | 28 |
Neural Mito Oragnelles (MO) Peptides | 30 |
2.2 Mechanism and Potentials of Stem Cells | 31 |
Advantage and Drawbacks of Various types of Cells | 32 |
Targeted Neural Precursor Stem Cells: Mechanism of Function | 33 |
CNS Remyelination Mechanism | 36 |
Mesenchymal Precursor Stem Cells: Mechanisms of Function | 40 |
Embryonic Stem Cells (ESC) and Induced Pluripotent Stem Cells (iPSC) | 41 |
2.3 Diet Facts and Management | 42 |
Fatty Acids as a Risk Factor in MS development | 44 |
Salt in Typical “Western Food” | 47 |
2.4 Physiotherapy in Treatment and Symptom Management | 49 |
Hyperbaric Oxygenation Therapy (HBOT) | 50 |
Morphogenetic Harmoniser System: The Scalar Plasma Wave Modulator | 52 |
Transcranial Direct Current Stimulation (tDCS) | 53 |
Transcranial Magnetic Stimulation (TMS) | 56 |
2.5 The Role of Memory Training Centres | 59 |
2.6 The Management of Spasticity | 60 |
Reference | 63 |